Yolanda Nesbeth Ph.D., received her Ph.D. in Microbiology and Immunology from Dartmouth Medical School. During her graduate career, she developed therapeutic cell-based technologies and immunotherapies against ovarian cancer. Yolanda previously worked as a Consultant with Clarion Healthcare providing strategic advice to pharmaceutical and biotechnology companies on key scientific and commercial matters related to drug development, promotion, and regulatory processes. Yolanda is currently a Director at Celdara Medical where she leads multiple SBIR/STTR – funded internal therapeutic development programs, in addition to managing a clinical lab providing molecular diagnostics for systemic sclerosis patients, clinicians, and drug developers. She serves as a Reviewer for DOD and NIH SBIR/STTR study sections and is a member of various biotech organizations.